---
title: Partnership Opportunities | Optinose
description: Find out more about becoming a partner with Optinose.
---

[![Optinose_logo_RGB](https://optinose.com/hs-fs/hubfs/Optinose_logo_RGB.png?width=196&name=Optinose_logo_RGB.png "Optinose_logo_RGB")](https://optinose.com/)

[Contact Us](https://optinose.com/contact-us)

This is a search field with an auto-suggest feature attached.

- There are no suggestions because the search field is empty.

- COMPANY
  
    - [PARTNERSHIP OPPORTUNITIES](https://optinose.com/company/partnership-opportunities)
    - [CORPORATE COMPLIANCE](https://optinose.com/company/corporate-compliance)
- [EXHALATION DELIVERY SYSTEMS](https://optinose.com/exhalation-delivery-systems/technical-overview)
  
    - [LIQUID DELIVERY](https://optinose.com/exhalation-delivery-systems/liquid-delivery-device)
    - [POWDER DELIVERY DEVICE](https://optinose.com/exhalation-delivery-systems/powder-delivery-device)
    - [ANATOMY OF THE NASAL PASSAGES](https://optinose.com/exhalation-delivery-systems/anatomy-of-the-nasal-passages)
    - [NASAL DELIVERY CHALLENGES](https://optinose.com/exhalation-delivery-systems/nasal-delivery-challenges)
- [THERAPEUTIC AREAS](https://optinose.com/therapeutic-areas)
- [PRODUCTS](https://optinose.com/products/products)
  
    - [XHANCE®](https://optinose.com/products/xhance-fluticasone-propionate)
    - [ONZETRA® Xsail®](https://optinose.com/products/onzetra-xsail)
- [RESEARCH & DEVELOPMENT](https://optinose.com/research-and-development/overview-chart)
  
    - [XHANCE® – FUTURE DEVELOPMENT](https://optinose.com/research-and-development/xhance-future-development)
    - [PARTNERSHIPS](https://optinose.com/research-and-development/partnerships)
- [NEWS & MEDIA](https://optinose.com/investigator-contact)
- [SCIENTIFIC COMMUNICATIONS](https://optinose.com/scientific-communications/peer-reviewed-journal-publications)

# Partnership Opportunities

Optinose has developed innovative devices that transform treatment by leveraging the nose for drug delivery in a manner that addresses traditional nasal administration.

Using known molecules, Optinose deepens and broadens tissue penetration, offering the potential to tackle previously intractable challenges, such as delivery across the nose-brain barrier, without deposition to the lung.

## Who Should Contact Optinose?

- Pharmaceutical and biotechnology companies interested in evaluating the nasal polyps or migraine applications
- Those seeking an innovative, non-oral, or non-injected delivery platform for their proprietary CNS, systemic, or topical nasal compounds
- Companies seeking to re-evaluate promising compounds that experienced clinical development challenges due to insufficient oral bioavailability, first-pass metabolism, or speed of onset
- Companies seeking to find new or improved uses for existing compounds

The Company offers both single and multi-use intranasal delivery devices for powder and liquid formulations.

### Our Purpose

The Optinose team is unified by a common shared mission: to improve lives.

### Company History

As an ear, nose, and throat (ENT) surgeon and clinician specializing in nasal and sinus diseases, Per Djupesland experienced firsthand the limitations of existing nasal drug delivery options.

[![Optinose_logo_RGB](https://optinose.com/hubfs/Optinose_logo_RGB.png)](https://optinose.com)

- [Contact Us](https://optinose.com/contact-us)
- [P.O. Terms & Conditions](https://optinose.com/po_terms_conditions)
- [Privacy Policy](https://optinose.com/privacy-policy)
- [Terms of Use](https://optinose.com/terms-of-use)
- [Site Map](https://optinose.com/site-map)

©2018 OptiNose US, Inc. OPTINOSE-17-013b 10/2017

[Powered by Atlas - a B2B SaaS HubSpot theme](https://www.kalungi.com/atlas-hubspot-theme-for-b2b-saas-software)